NICE eczema in under 12s guideline
An easy-to-follow NICE guideline summary on the management of atopic eczema in children under 12
ROS guideline: vitamin D and bone health in children
A clear summary on the management of vitamin D deficiency in children and young people.
NICE CKS on teething
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. Please refer to the full guideline for the complete set of recommendations.
NICE CKS—cow’s milk allergy in children
Be aware that the clinical features of cow’s milk allergy are variable in type and severity and can overlap with other common conditions, so clinical judgement is needed when interpreting symptoms.
NICE fever in under 5s guideline
A summary of the 2019 updated NICE guideline on fever in under 5s with a ‘traffic light’ approach to assessing risk, and features of specific diseases
NICE GORD in children guideline
A useful NICE guideline summary on the recognition, diagnosis, and management of GORD in children and young people.
NICE depression in children and young people guideline
This summary covers assessing people aged 5–18 years for depression and appropriate management strategies based on severity.
NICE guideline: UTI in children and young people
This 2017 updated summary covers diagnosis and follow-up. Includes updated advice on urine testing strategies in children under 3 years
PHE whooping cough guideline
Summary of PHE guidance on the management of whooping cough covers testing and includes an algorithm on the management of patients with the condition.
Let’s talk about weight in children guideline
This summary relates to families of 4–12-year-old children and young people, covering how to discuss weight, and support positive lifestyle changes.
Resource hub
Educational resources
APPROPRIATE FEVER RELIEF FOR CHILDREN
This concise consultation card was developed by Guidelines for Pharmacy in partnership with RB UK.
Essential information and adverse reporting details are included.
RB-M-30635 February 2021
Use of unlicensed medicines in paediatric patients guideline
This guideline was developed by a multidisciplinary expert panel: Tomlin S et al with the support of a grant from Rosemont Pharmaceuticals Ltd.